UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.713-720

2020

Volltextzugriff (PDF)

Einleitung

Klaus Grubmüller, Bernhard Schnell, Klaus Grubmüller, Bernhard Schnell

2018

Volltextzugriff (PDF)

Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer

The Prostate, 2020-01, Vol.80 (1), p.74-82

2020

Volltextzugriff (PDF)

PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact

Clinical cancer research, 2018-12, Vol.24 (24), p.6300-6307

2018

Volltextzugriff (PDF)

Text Q–Z

Reprint 2018 edition, 2018

Volltextzugriff (PDF)

Text L–P

Reprint 2018 edition, 2018

Volltextzugriff (PDF)

Text D–K

Reprint 2018 edition, 2018

Volltextzugriff (PDF)

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer

The Journal of nuclear medicine (1978), 2023-11, Vol.64 (11), p.1730-1736

2023

Volltextzugriff (PDF)

Ein Clip zu viel

Urologie (Heidelberg, Germany), 2023-04, Vol.62 (4), p.389-391

2023

Volltextzugriff (PDF)

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

European radiology, 2021-06, Vol.31 (6), p.3754-3764

2021

Volltextzugriff (PDF)

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer

Current oncology (Toronto), 2023-01, Vol.30 (2), p.1683-1691

2023

Volltextzugriff (PDF)

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response

Current oncology (Toronto), 2021-07, Vol.28 (4), p.2881-2892

2021

Volltextzugriff (PDF)

Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET

Urologic oncology, 2024-04, Vol.42 (4), p.115.e9-115.e16

2024

Volltextzugriff (PDF)

Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

European urology open science (Online), 2022-06, Vol.40, p.117-124

2022

Volltextzugriff (PDF)

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

Current oncology (Toronto), 2021-09, Vol.28 (5), p.3692-3704

2021

Volltextzugriff (PDF)

Text A–C

Klaus Grubmüller, Bernhard Schnell, Klaus Grubmüller, Bernhard Schnell

2018

Volltextzugriff (PDF)

Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer

European journal of nuclear medicine and molecular imaging, 2021-05, Vol.48 (5), p.1650-1657

2021

Volltextzugriff (PDF)

Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI)

Prostate cancer and prostatic diseases, 2021-06, Vol.24 (2), p.439-447

2021

Volltextzugriff (PDF)

The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance

Mini reviews in medicinal chemistry, 2016-01, Vol.16 (18), p.1444-1449

2016

Volltextzugriff (PDF)

MUW researcher of the month

Wiener Klinische Wochenschrift, 2018-12, Vol.130 (23-24), p.740-741

Grubmüller, Bernhard

2018

Volltextzugriff (PDF)

One clip too many

Urologie (Heidelberg, Germany), 2023-04, Vol.62 (4), p.389-391

2023

Volltextzugriff (PDF)

Laparoscopic Cryoablation Versus Partial Nephrectomy for the Treatment of Small Renal Masses: Systematic Review and Cumulative Analysis of Observational Studies

European urology, 2011-09, Vol.60 (3), p.435-443

2011

Volltextzugriff (PDF)

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer

Journal of Nuclear Medicine, 2023-06, Vol.64 (6), p.863-868

2023

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(74)
Deutsch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(31)
Prostate Cancer
(27)
Humans
(24)
Male
(20)
Oncology
(17)
Aged
(14)
Urology & Nephrology
(13)
Medicine
(11)
Medicine & Public Health
(11)
Metastases
(11)
Patients
(11)
Retrospective Studies
(11)
Castration
(9)
Magnetic Resonance Imaging
(9)
Metastasis
(9)
Middle Aged
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Technology
(9)
Original
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks

Einleitung

Response assessment using [68Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer

PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact

Text Q–Z

Text L–P

Text D–K

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer

Ein Clip zu viel

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response

Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET

Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies

Text A–C

Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer

Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI)

The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance

MUW researcher of the month

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer

One clip too many

Laparoscopic Cryoablation Versus Partial Nephrectomy for the Treatment of Small Renal Masses: Systematic Review and Cumulative Analysis of Observational Studies

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer

Suchergebnisse filtern